InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019

September 12, 2019

Read More »

InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

September 3, 2019

Read More »

InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit

August 29, 2019

Read More »

InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes

August 2, 2019

Read More »

InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors

July 2, 2019

Read More »

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

May 15, 2019

Read More »

InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

May 8, 2019

Read More »

InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

March 18, 2019

Read More »

InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program

March 13, 2019

Read More »

InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019

March 12, 2019

Read More »

InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board

March 6, 2019

Read More »

InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

February 12, 2019

Read More »

InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019

February 5, 2019

Read More »

InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer

January 11, 2019

Read More »

InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019

January 3, 2019

Read More »

InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program

December 4, 2018

Read More »

InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

November 12, 2018

Read More »

InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018

November 5, 2018

Read More »

InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls

November 5, 2018

Read More »

InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018

October 10, 2018

Read More »